The phrase "authorisations regarding" is correct and usable in written English.
It can be used when discussing permissions or approvals related to a specific subject or matter.
Example: "The company has received all necessary authorisations regarding the new project implementation."
Alternatives: "permissions concerning" or "approvals related to".
There is no requirement in the marketing authorisation regarding the number of manufacturing sites.
Regarding authorisations misused by big tech firms, I am very proud that many of my amendments are included in the final compromises.
Our own call centre for community services is in lockdown and unable to receive any information regarding authorisation for drug changes or referrals.
Consult Senior Manager/Head regarding authorisation.
(29) Direct rules regarding the authorisation and supervision of CCPs are an essential corollary to the obligation to clear OTC derivatives.
Additionally, in February 2016 the European Ombudsman reached its conclusion in case 12/2013/MDC on the practices of the European Commission regarding the authorisation and placing on the market of PPPs.The Commission, in its risk manager role, has the duty to ensure that the active substances it approves are not harmful for human health, animal health, or the environment.
In particular support is offered regarding the registration, evaluation and authorisation procedures as well as the classification and labelling of chemicals.
In doing so we will explore the perceived need for parental authorisation, levels of deliberation and identify perceptions regarding the necessary components required for permissible approaches to participation in newborn screening programmes.
At the same time REACH enforcement in 18 EEA countries shows very low numbers regarding non-compliance in reference to the authorisation regime de lege lata (three cases of non-compliances in 421 inspections) [25].
Firstly the retrospective collection of information in accordance with Article 45 where it obliges the marketing authorisation holder of a medicinal product to provide all information regarding clinical trials in children which are already completed at latest by January 26 2008 to the competent authorities.
